Leap Therapeutics, Inc. (LPTX) reported a wider loss for the second quarter, falling short of Wall Street expectations.
The company posted a net loss of $20.36 million, or $0.52 per share, compared to a loss of $13.39 million, or $0.91 per share, during the same quarter last year.
On average, analysts had predicted a loss of $0.43 per share, based on data collected by Thomson Reuters. It is important to note that analysts' projections usually exclude special items.
Key Financial Highlights (GAAP) for Leap Therapeutics, Inc. (LPTX):
- Net Loss for Q2: $20.36 million compared to $13.39 million in the previous year.
- Earnings Per Share (EPS) for Q2: $0.52 compared to $0.91 in the previous year.
